Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06068400 · TERMINATED
Trial details
- NCT number
- NCT06068400
- Sponsor
- Guangzhou Bio-gene Technology Co., Ltd
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2024-02-02
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.